Concepedia

Ming‐Dauh Wang

MW

8

Publications

341

Citations

8

H-Index

2005

Active since

Affiliations

Eli Lilly (United States)(Current)

Ming‐Dauh Wang is an author at Eli Lilly (United States) specializing in patient safety, time-varying confounding, and clinical trials.

Top concepts

Publications per year

2005–2018

8

Publications

8

Bayesian predictive approach to interim monitoring in clinical trials

Alexei Dmitrienko, Ming‐Dauh Wang · Statistics in Medicine · 2005 · 128 citations

Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study

John J.P. Kastelein, Steven E. Nissen, Daniel J. Rader et al. · European Heart Journal · 2016 · 76 citations · Full text

Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome

John S. Millar, Danielle Duffy, Ramprasad Gadi et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 42 citations · Full text

Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults

Jeffrey G. Suico, Ming‐Dauh Wang, Stuart Friedrich et al. · Journal of Pharmacy and Pharmacology · 2014 · 34 citations · Full text

Sample Size Reestimation by Bayesian Prediction

Ming‐Dauh Wang · Biometrical Journal · 2007 · 28 citations

Rows per page

1–5 of 8